AmandaNizamMD

PubMed

• 34 citations
  Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
  Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman
  Cancer. 2022-03-15
• 27 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati
  JAMA Oncology. 2023-01-01
• 220 citations
  Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
  Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy
  Annals of Oncology. 2021-06-01

Journal Articles

• The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer  
  Nizam A, Brea LP, Gupta B, Aragon-Ching JB, Kidney Cancer, 4/5/2019

Abstracts/Posters

• Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts)
  Nizam A, Tzeng A, Wei W, Rayman PA, Pavicic PG, Makarov V, Juric I, Alban T, Swaidani S, Sheng IY, Gilligan TD, Gupta S, Diaz-Montero CM, Ornstein MC, Poster presentation at American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA, 2/18/2022
• Safety and efficacy outcomes in immune checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts) requiring treatment interruption (TI) du...
  Nizam A, Sheng IY, Allman KD, Martin A, Gilligan TD, Gupta S, Ornstein MC., Poster presentation at American Society of Clinical Oncology Genitourinary Cancers Symposium, Virtual, 2/11/2021
• Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients
  Dawsey S, Pennell NA, Lemmon C, Nizam A, Wei W, Gilligan TD, Ornstein MC, Gupta S, Poster presentation at American Association for Cancer Research COVID-19 and Cancer Meeting, Virtual, 2/3/2021
• Retrospective analysis of immune-related adverse events (irAE) in metastatic renal cell carcinoma (mRCC) patients treated with first-line ipilimumab and nivolumab (I+N)
  Desai K, Rybicki LA, Nizam A, Wood LS, Allman KD, Martin A, Calabrese C, Gilligan TD, Gupta S, Ornstein MC, Journal of Clinical Oncology, 5/25/2020
• Carcinomas of the renal pelvis, ureters, and urinary bladder arise by similar carcinogenic pathways: A pathoepidemiological analysis
  Nizam A, Henson DE, Aragon-Ching JB, Poster presentation at American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA, 2/15/2019
• Bloody Bladder: Where do we go from here?
  Nizam A, Aragon-Ching JB, Poster presentation at American College of Physicians National Meeting, New Orleans, LA, 4/19/2018
• Molecular characterization of brain metastases in patients with metastatic urothelial cancers
  Nizam A, Trump DL, Aragon-Ching JB, Poster presentation at American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA, 2/8/2018
• Closing the Curtain: Amaurosis Fugax as the Initial Presentation of Paroxysmal Nocturnal Hemoglobinuria
  Millado K, Nizam A, Catalanotti JS, Oral presentation at American College of Physicians National Meeting, San Diego, CA, 3/30/2017
• Retrospective review of clear cell and non-clear cell renal carcinomas: Characteristics and course in the pre-TKI (tyrosine kinase inhibitor) and post-TKI era
  Gupta K, Nizam A, Millado K, Liu J, Guebre-Xabiher H, Nguyen H, Siegel RS, Aragon-Ching JB, Journal of Clinical Oncology, 2017
• Advanced signet ring cell type gastroesophageal cancers in Central American patients age 40 and below: A summary of one tertiary care center's experience and a review ...
  Cannon TL, Ershler WB, Bijelic L, Nizam A, Hosseini N, Journal of Clinical Oncology, 2017
• Join now to see all